Attix Pharmaceuticals Recalls Sulfanilamide Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Sulfanilamide active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. According to the rubric, FDA Class II recalls involving significant injury risks or hospitalization reports are rated as Severe (4). Penicillin cross-contamination poses a significant risk of severe allergic reactions.
Plain-English summary
Attix Pharmaceuticals is recalling Sulfanilamide active pharmaceutical ingredient (API) packaged in bags or drums. The recall covers all lots repackaged and distributed between January 5, 2012, and February 12, 2015. The total quantity involved is 33,895 grams.
The recall was initiated because the product was repackaged in a facility that also handled penicillin products without adequate separation. This process created a potential for cross-contamination with penicillin.
The affected product was distributed nationwide to compounding pharmacies and research organizations. Consumers and healthcare providers should stop using the recalled product and contact their supplier or the recalling firm for instructions on return or disposal.
The recalled product
- Product
- Sulfanilamide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
- Manufacturer
- Attix Pharmaceuticals
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots repackaged and distributed between 01/05/12 to 02/12/15
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 470 recalled by Attix Pharmaceuticals under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 470 products in this recall →Related recalls
Same manufacturer · Attix Pharmaceuticals
See all →- SevereAttix Pharmaceuticals Recalls Idebenone Due to Penicillin Cross Contamination Risk
FDA (Drugs) · 2015-04-29
- SevereAttix Pharmaceuticals Recalls Methylprednisolone Base Due to Penicillin Cross-Contamination Risk
FDA (Drugs) · 2015-04-29
- SevereCarbazochrome API Recalled for Potential Penicillin Cross Contamination
FDA (Drugs) · 2015-04-29
- SevereAttix Pharmaceuticals Recalls Cidofovir Dihydrate Due to Penicillin Cross-Contamination Risk
FDA (Drugs) · 2015-04-29
- SevereAttix Pharmaceuticals Recalls Pheniramine Maleate Due to Penicillin Cross-Contamination Risk
FDA (Drugs) · 2015-04-29
Same hazard · cross contamination
See all →- HighFDA Recalls Performance Pro Nitrile Gloves Due to Defects
FDA (Devices) · 2026-10-07
- HighFDA Recalls Defective Blue Nitrile Patient Examination Gloves
FDA (Devices) · 2026-10-07
- HighFDA Recalls Opportunity Pro Nitrile Gloves Due to Manufacturing Defects
FDA (Devices) · 2026-10-07
- ModerateSage Products Recalls Chlorhexidine Gluconate Cloth Due to Cross Contamination
FDA (Drugs) · 2026-09-09
- CriticalCetirizine Hydrochloride Tablets Recalled Due to Cross Contamination with Ranitidine
FDA (Drugs) · 2026-07-29
Similar recalls
- SevereMethyfolate Injection Recalled for Potential Penicillin Contamination
FDA (Drugs) · 2015-12-09
- HighFreedom Pharmaceuticals Recalls Domperidone API Due to Penicillin Cross-Contamination
FDA (Drugs) · 2016-01-20
- SevereLife Science Pharmacy Recalls Compounded Estriol Capsules Due to Penicillin Contamination
FDA (Drugs) · 2015-12-09
- SevereMethyfolate Capsules Recalled for Potential Penicillin Cross Contamination
FDA (Drugs) · 2015-12-09
- HighLife Science Pharmacy Recalls Compounded Estriol Gels Due to Penicillin Contamination
FDA (Drugs) · 2015-12-09
- SevereLife Science Pharmacy Recalls Hydroxocobalamin Injection Due to Penicillin Contamination
FDA (Drugs) · 2015-12-09